Case History: A 70-year-old male, non-diabetic, non-hypertensive presented with acute history of sudden onset memory loss and hallucinations.
Case History: A 70-year-old male, non-diabetic, non-hypertensive presented with acute history of sudden onset memory loss and hallucinations. No focal neurological deficit was found on clinical examination and vital parameters were stable. Patient was referred for contrast enhanced MRI brain. There was no history of trauma.
Figure 1: T2 hyperintense bilateral caudate nucleus and putamen. Mild age related cortical atrophy is seen.
[[{"type":"media","view_mode":"media_crop","fid":"20005","attributes":{"alt":"","class":"media-image","id":"media_crop_9151422341743","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1232","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Figures 2 and 3: Diffusion restriction in bilateral caudate nucleus and putamen. Rest of the brain parenchyma appears normal.
[[{"type":"media","view_mode":"media_crop","fid":"20006","attributes":{"alt":"","class":"media-image","id":"media_crop_8696004379871","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1233","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Figure 3
[[{"type":"media","view_mode":"media_crop","fid":"20007","attributes":{"alt":"","class":"media-image","id":"media_crop_5942126515864","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1234","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Figure 4: FLAIR hyperintensity in bilateral caudate nucleus and putamen.
[[{"type":"media","view_mode":"media_crop","fid":"20008","attributes":{"alt":"","class":"media-image","id":"media_crop_7362427192334","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1235","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Figure 5: No abnormal contrast enhancement in these regions and rest of the brain.
Findings: MRI revealed T2 and FLAIR hyper-intensities in bilateral caudate nucleus and putamen which revealed restriction on diffusion weighted images with low ADC values. Rest of the brain parenchyma showed changes of age related cortical atrophy. No area of abnormal contrast enhancement was seen.
Diagnosis: Creutzfeldt Jakob's disease (CJD)
Discussion: CJD is a neurological spongiform encephalopathy caused by prions that is incurable and invariably fatal. The worldwide prevalence of Creutzfeldt-Jakob disease is approximately one person in 1 million, and its annual incidence is one person in 2 million.
Rapidly progressive mental deterioration with dementia, the most characteristic clinical finding, begins within a few weeks after onset. Pyramidal and extrapyramidal symptoms develop as the disease progresses, with the appearance of periodic synchronous discharges on the electroencephalogram (EEG) and of myoclonus, both of which are characteristic features of Creutzfeldt-Jakob disease. A few months later, the akinetic mutism stage begins. Patients typically die of a respiratory tract infection within one year of the disease onset.
Progressive brain atrophy and areas of high signal intensity in the cerebral cortex, thalamus and basal ganglia are well-known features depicted on T2-weighted magnetic resonance (MR) images. However, in the early stage of disease, the appearance of the brain on T2-weighted MR images often is normal, and it may be impossible on that basis to reach a diagnosis. Diffusion-weighted imaging is a useful modality for the early diagnosis of this disease even before the characteristic periodic synchronous EEG changes.
Differentials of this disease include:
- Alzheimer disease - no diffusion abnormalities.
- Vascular dementia - multiple infarcts, but diffusion-weighted imaging abnormalities are observed only in the area of a recent infarction, and there is no diffuse cortical involvement.
- MELAS - occur in younger age, diffusion abnormalities spare the underlying white matter.
- Venous hypertensive encephalopathy - MRI may show cortical signal abnormalities and associated venous fistula if any.
- Chronic herpes simplex encephalitis - frontal and temporal lobe involvement with areas of hemorrhage.
Rozil Gandhi, DMRD, DNB
Senior fellow in Interventional Radiology
Tata Memorial Hospital, Mumbai, India
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.